January 23–25, 2024
The Mayflower Hotel
1127 Connecticut Avenue, NW
Washington, DC 20036, US

BOOTH: #18

We look forward to meeting you at WCBP 2024.

Request a meeting with our team to learn how we help our clients advance their drug development programs.

Schedule a Meeting

Speak with our scientific experts onsite to discuss your project.

I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.



BioAgilytix Presentation at WCBP Symposium

Potency Assays for ATMPs – Selection of Assay Platforms and Data Processing Methods are Key Aspects for Successful Control Strategies

Wednesday, January 24, 2024
12:30 – 1:30 p.m.

Jeff Patrick, Ph.D.,  - Senior Director of CMC Bioanalytical Operations - BioAgilytix
Shiqian Zhu, Ph.D.,  - Director of CMC Bioanalytical Operations – BioAgilytix

Partner with BioAgilytix for analytical testing services for biopharmaceutical product development

BioAgilytix has expertise with a wide array of CMC bioanalytical readouts across many therapeutic modalities. Our specialized CMC scientists can leverage their decades of combined knowledge to provide guidance for designing the appropriate manufacturing support package for your therapeutic from purity and sterility testing to potency assays for lot release testing. BioAgilytix can support your biopharmaceutical product through all phases of drug development and we are committed to finding the most efficient and appropriate path to advance your project.

With our global network of advanced laboratories and highly experienced scientists, BioAgilytix allows sponsors to effectively address these and other challenges facing successful CMC assay development.

Learn about our CMC bioanalytical services and fill out the form to schedule a meeting with our experts onsite.

Speak with our team to learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic. Please fill out the form, and a CMC specialist will reach out to schedule a meeting with you onsite.

About the event

The WCBP Symposium has established a reputation as one of the highest-regarded annual conferences addressing the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives. This year, WCBP 2024 will be co-sponsored by the US FDA. Effective communication and intellectual collaboration between regulators and industry leaders around the regulatory expectations for applying these new technologies in the CMC space is a critical part of future scientific advancements for drug developers.